Migraine and Encephalitis

Summary:

Encephalitis is found among people with Migraine, especially for people who are female, 50-59 old.

The study analyzes which people have Encephalitis with Migraine. It is created by eHealthMe based on reports of 31 people who have Migraine from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Migraine?

Migraine (headache) is found to be associated with 2,053 drugs and 2,353 conditions by eHealthMe. Check the latest studies of Migraine.

What is Encephalitis?

Encephalitis (inflammation of the brain) is found to be associated with 655 drugs and 848 conditions by eHealthMe. Check the latest studies of Encephalitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

31 people who have Migraine and Encephalitis are studied.

Would you have Encephalitis when you have Migraine?

Gender of people who have Migraine and experienced Encephalitis *:

  • female: 87.1 %
  • male: 12.9 %

Age of people who have Migraine and experienced Encephalitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 7.41 %
  • 20-29: 22.22 %
  • 30-39: 11.11 %
  • 40-49: 22.22 %
  • 50-59: 22.22 %
  • 60+: 14.81 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 7 people, 22.58%
  2. Headache (pain in head): 7 people, 22.58%
  3. Pain: 7 people, 22.58%
  4. Depression: 6 people, 19.35%
  5. Iron Deficiency Anaemia: 5 people, 16.13%
  6. Dysmenorrhea (painful menstruation): 5 people, 16.13%
  7. Cough: 5 people, 16.13%
  8. Rashes (redness): 5 people, 16.13%
  9. Joint Pain: 5 people, 16.13%
  10. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 12.90%

Common drugs taken by these people *:

  1. Topamax: 8 people, 25.81%
  2. Lyrica: 5 people, 16.13%
  3. Maxalt: 5 people, 16.13%
  4. Mcp: 5 people, 16.13%
  5. Buscopan: 5 people, 16.13%
  6. Cymbalta: 4 people, 12.90%
  7. Hydroxyzine: 3 people, 9.68%
  8. Sumatriptan: 3 people, 9.68%
  9. Prozac: 3 people, 9.68%
  10. Omeprazole: 3 people, 9.68%

Common symptoms for these people *:

  1. Pneumonia: 7 people, 22.58%
  2. Oesophagitis (inflammation of oesophagus): 5 people, 16.13%
  3. Fever: 5 people, 16.13%
  4. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 4 people, 12.90%
  5. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 4 people, 12.90%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 9.68%
  7. Speech Disorder: 3 people, 9.68%
  8. Urinary Tract Infection: 3 people, 9.68%
  9. Memory Loss: 3 people, 9.68%
  10. Drug Ineffective: 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Encephalitis?

- Check whether Encephalitis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Encephalitis:

All the conditions that are associated with Encephalitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Encephalitis and Migraine, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: